82 FR 12230 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 82, Issue 39 (March 1, 2017)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 82, Issue 39 (March 1, 2017)
| Page Range | 12230-12232 | |
| FR Document | 2017-03948 |
[Federal Register Volume 82, Number 39 (Wednesday, March 1, 2017)] [Notices] [Pages 12230-12232] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-03948] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http://www.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). SUPPLEMENTARY INFORMATION: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance [[Page 12231]] testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated November 25, 2008 (73 FR 71858), the following HHS-certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities Dynacare, 6628 50th Street NW., Edmonton, AB Canada T6B 2N7, 780-784- 1190, (Formerly: Gamma-Dynacare Medical Laboratories). HHS-Certified Laboratories ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 844-486-9226. Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 37210, 615-255-2400, (Formerly: Aegis Sciences Corporation, Aegis Analytical Laboratories, Inc., Aegis Analytical Laboratories). Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361- 8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.). Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130, (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.). Baptist Medical Center--Toxicology Laboratory, 11401 I-30, Little Rock, AR 72209-7056, 501-202-2783, (Formerly: Forensic Toxicology Laboratory Baptist Medical Center). Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 66215-2802, 800-445-6917. DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800- 235-4890. Dynacare,* 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679- 1630, (Formerly: Gamma-Dynacare Medical Laboratories). ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609. Fortes Laboratories, Inc., 25749 SW Canyon Creek Road, Suite 600, Wilsonville, OR 97070, 503-486-1023. Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical Laboratories, Inc.). Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group). Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866-827-8042/800-233-6339, (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center). LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845, (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.). MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, Testing for Veterans Affairs (VA) Employees Only. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515. One Source Toxicology Laboratory, In, 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory). Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology Laboratory). Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509-755-8991/800-541-7891x7. Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635- 5840. Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 800-729-6432, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 91304, 818-737-6370, (Formerly: SmithKline Beecham Clinical Laboratories). Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 95403, 800-255-2159. STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421, 800-442-0438. U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for Department of Defense (DoD) Employees Only. The following laboratory has voluntarily withdrawn from the National Laboratory Certification Program, as of January 6, 2017: Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040, 602-438-8507/800-279-0027. * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on November 25, 2008 (73 FR 71858). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in [[Page 12232]] the NLCP certification maintenance program. Brian Makela, Chemist. [FR Doc. 2017-03948 Filed 2-28-17; 8:45 am] BILLING CODE 4162-20-P
![12230 Federal Register / Vol. 82, No. 39 / Wednesday, March 1, 2017 / Notices
speakers for the scheduled open public would constitute a clearly unwarranted SUMMARY: The Department of Health and
hearing session. The contact person will invasion of personal privacy. Human Services (HHS) notifies federal
notify interested persons regarding their Name of Committee: Center for Scientific agencies of the laboratories and
request to speak by March 21, 2017. Review Special Emphasis Panel; Biomedical Instrumented Initial Testing Facilities
Closed Committee Deliberations: On Engineering. (IITF) currently certified to meet the
April 5, 2017, from 11:15 a.m. to 12:00 Date: March 2–3, 2017. standards of the Mandatory Guidelines
p.m., the meeting will be closed to Time: 8:00 a.m. to 9:00 p.m. for Federal Workplace Drug Testing
permit discussion where disclosure Agenda: To review and evaluate grant Programs (Mandatory Guidelines).
applications.
would constitute a clearly unwarranted Place: National Institutes of Health, 6701
A notice listing all currently HHS-
invasion of personal privacy (5 U.S.C. Rockledge Drive, Bethesda, MD 20892 certified laboratories and IITFs is
552b(c)(6)). The Committee will discuss (Virtual Meeting). published in the Federal Register
the report of the intramural research Contact Person: Joseph D Mosca, Ph.D., during the first week of each month. If
program and make recommendations Scientific Review Officer, Center for any laboratory or IITF certification is
regarding personnel staffing decisions. Scientific Review, National Institutes of suspended or revoked, the laboratory or
Persons attending FDA’s advisory Health, 6701 Rockledge Drive, Room 5158, IITF will be omitted from subsequent
MSC 7808, Bethesda, MD 20892, (301) 435– lists until such time as it is restored to
committee meetings are advised that the
2344, moscajos@csr.nih.gov.
Agency is not responsible for providing full certification under the Mandatory
This notice is being published less than 15 Guidelines.
access to electrical outlets. days prior to the meeting due to the timing
FDA welcomes the attendance of the limitations imposed by the review and If any laboratory or IITF has
public at its advisory committee funding cycle. withdrawn from the HHS National
meetings and will make every effort to Name of Committee: Center for Scientific Laboratory Certification Program (NLCP)
accommodate persons with disabilities. Review Special Emphasis Panel; Member during the past month, it will be listed
If you require accommodations due to a Conflict: Health Services Organization and at the end and will be omitted from the
disability, please contact Bryan Emery Delivery. monthly listing thereafter.
at least 7 days in advance of the Date: March 6, 2017. This notice is also available on the
meeting. Time: 8:00 a.m. to 5:00 p.m. Internet at http://www.samhsa.gov/
Agenda: To review and evaluate grant
FDA is committed to the orderly applications.
workplace.
conduct of its advisory committee Place: National Institutes of Health, 6701 FOR FURTHER INFORMATION CONTACT:
meetings. Please visit our Web site at Rockledge Drive, Bethesda, MD 20892 Giselle Hersh, Division of Workplace
http://www.fda.gov/Advisory (Telephone Conference Call). Programs, SAMHSA/CSAP, 5600
Committees/AboutAdvisoryCommittees/ Contact Person: Gabriel B Fosu, Ph.D.,
Fishers Lane, Room 16N03A, Rockville,
ucm111462.htm for procedures on Scientific Review Officer, Center for
Scientific Review, National Institutes of Maryland 20857; 240–276–2600 (voice).
public conduct during advisory
committee meetings. Health, 6701 Rockledge Drive, Room 3108, SUPPLEMENTARY INFORMATION: The
MSC 7808, Bethesda, MD 20892, (301) 435– Department of Health and Human
Notice of this meeting is given under 3562, fosug@csr.nih.gov.
the Federal Advisory Committee Act (5 Services (HHS) notifies federal agencies
This notice is being published less than 15 of the laboratories and Instrumented
U.S.C. app. 2). days prior to the meeting due to the timing Initial Testing Facilities (IITF) currently
Dated: February 24, 2017. limitations imposed by the review and
funding cycle.
certified to meet the standards of the
Janice M. Soreth, Mandatory Guidelines for Federal
Associate Commissioner for Special Medical (Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
Workplace Drug Testing Programs
Programs. (Mandatory Guidelines). The Mandatory
93.333, Clinical Research, 93.306, 93.333,
[FR Doc. 2017–03944 Filed 2–28–17; 8:45 am] 93.337, 93.393–93.396, 93.837–93.844, Guidelines were first published in the
BILLING CODE 4164–01–P 93.846–93.878, 93.892, 93.893, National Federal Register on April 11, 1988 (53
Institutes of Health, HHS) FR 11970), and subsequently revised in
Dated: February 23, 2017. the Federal Register on June 9, 1994 (59
DEPARTMENT OF HEALTH AND FR 29908); September 30, 1997 (62 FR
Michelle Trout,
HUMAN SERVICES 51118); April 13, 2004 (69 FR 19644);
Program Analyst, Office of Federal Advisory
Committee Policy. November 25, 2008 (73 FR 71858);
National Institutes of Health December 10, 2008 (73 FR 75122); and
[FR Doc. 2017–03903 Filed 2–28–17; 8:45 am]
Center for Scientific Review; Notice of on April 30, 2010 (75 FR 22809).
BILLING CODE 4140–01–P
Closed Meetings The Mandatory Guidelines were
initially developed in accordance with
Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND Executive Order 12564 and section 503
Federal Advisory Committee Act, as HUMAN SERVICES of Public Law 100–71. The ‘‘Mandatory
amended (5 U.S.C. App.), notice is Guidelines for Federal Workplace Drug
hereby given of the following meetings. Substance Abuse and Mental Health Testing Programs,’’ as amended in the
The meetings will be closed to the Services Administration revisions listed above, requires strict
public in accordance with the standards that laboratories and IITFs
provisions set forth in sections Current List of HHS-Certified must meet in order to conduct drug and
asabaliauskas on DSK3SPTVN1PROD with NOTICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Laboratories and Instrumented Initial specimen validity tests on urine
as amended. The grant applications and Testing Facilities Which Meet Minimum specimens for federal agencies.
the discussions could disclose Standards To Engage in Urine Drug To become certified, an applicant
confidential trade secrets or commercial Testing for Federal Agencies laboratory or IITF must undergo three
property such as patentable material, AGENCY: Substance Abuse and Mental rounds of performance testing plus an
and personal information concerning Health Services Administration, HHS. on-site inspection. To maintain that
individuals associated with the grant certification, a laboratory or IITF must
ACTION: Notice.
applications, the disclosure of which participate in a quarterly performance
VerDate Sep<11>2014 18:09 Feb 28, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\01MRN1.SGM 01MRN1](https://thefederalregister.org/doc/82_FR_12269/page/1.svg)
![12232 Federal Register / Vol. 82, No. 39 / Wednesday, March 1, 2017 / Notices
the NLCP certification maintenance been approved to gauge petroleum and petroleum products for customs
program. certain petroleum products and purposes, in accordance with the
accredited to test petroleum and certain provisions of 19 CFR 151.12 and 19 CFR
Brian Makela,
petroleum products for customs 151.13. Inspectorate America
Chemist. purposes for the next three years as of Corporation is approved for the
[FR Doc. 2017–03948 Filed 2–28–17; 8:45 am] June 16, 2016. following gauging procedures for
BILLING CODE 4162–20–P DATES: The accreditation and approval petroleum and certain petroleum
of Inspectorate America Corporation as products from the American Petroleum
commercial gauger and laboratory Institute (API):
DEPARTMENT OF HOMELAND became effective on June 16, 2016. The
SECURITY next triennial inspection date will be API Chapters Title
scheduled for June 2019.
U.S. Customs and Border Protection FOR FURTHER INFORMATION CONTACT: 3 ..................... Tank Gauging
Approved Gauger and Accredited 7 ..................... Temperature Determination
Accreditation and Approval of
Laboratories Manager, Laboratories and 8 ..................... Sampling
Inspectorate America Corporation, as a
Scientific Services Directorate, U.S. 9 ..................... Density Determination
Commercial Gauger and Laboratory
Customs and Border Protection, 1300 12 ................... Calculations
AGENCY: U.S. Customs and Border Pennsylvania Avenue NW., Suite 17 ................... Marine Measurement
Protection, Department of Homeland 1500N, Washington, DC 20229, tel. 202–
Security. 344–1060. Inspectorate America Corporation is
ACTION: Notice of accreditation and SUPPLEMENTARY INFORMATION: Notice is accredited for the following laboratory
approval of Inspectorate America hereby given pursuant to 19 CFR 151.12 analysis procedures and methods for
Corporation as a commercial gauger and and 19 CFR 151.13, that Inspectorate petroleum and certain petroleum
laboratory. America Corporation, 33 Rigby Road, products set forth by the U.S. Customs
South Portland, ME 04106 has been and Border Protection Laboratory
SUMMARY: Notice is hereby given, approved to gauge petroleum and Methods (CBPL) and American Society
pursuant to CBP regulations, that certain petroleum products and for Testing and Materials (ASTM):
Inspectorate America Corporation has accredited to test petroleum and certain
CBPL No. ASTM Title
27–04 .............. D 95 ............... Standard Test Method for Water in Petroleum Products and Bituminous Materials by Distillation.
27–06 .............. D 473 ............. Standard Test Method for Sediment in Crude Oils and Fuel Oils by the Extraction Method.
27–11 .............. D 445 ............. Standard Test Method for Kinematic Viscosity of Transparent and Opaque Liquids (and Calculation of Dy-
namic Viscosity).
27–13 .............. D 4294 ........... Standard Test Method for Sulfur in Petroleum and Petroleum Products by Energy Dispersive X-ray Fluores-
cence Spectrometry.
27–46 .............. D 5002 ........... Standard Test Method for Density and Relative Density of Crude Oils by Digital Density Analyzer.
Anyone wishing to employ this entity DEPARTMENT OF HOMELAND Laboratories Manager, Laboratories and
to conduct laboratory analyses and SECURITY Scientific Services Directorate, U.S.
gauger services should request and Customs and Border Protection, 1300
receive written assurances from the U.S. Customs and Border Protection Pennsylvania Avenue NW., Suite
entity that it is accredited or approved 1500N, Washington, DC 20229, tel. 202–
Approval of Inspectorate America 344–1060.
by the U.S. Customs and Border
Corporation, as a Commercial Gauger
Protection to conduct the specific test or SUPPLEMENTARY INFORMATION: Notice is
gauger service requested. Alternatively, AGENCY: U.S. Customs and Border hereby given pursuant to 19 CFR 151.13,
inquiries regarding the specific test or Protection, Department of Homeland that Inspectorate America Corporation,
gauger service this entity is accredited Security. 3000 N. Main Street, Suite 1B, Baytown,
or approved to perform may be directed ACTION: Notice of approval of TX 77251, has been approved to gauge
to the U.S. Customs and Border Inspectorate America Corporation as a petroleum and certain petroleum
Protection by calling (202) 344–1060. commercial gauger. products for customs purposes, in
The inquiry may also be sent to accordance with the provisions of 19
CBPGaugersLabs@cbp.dhs.gov. Please SUMMARY: Notice is hereby given,
pursuant to CBP regulations, that CFR 151.13. Inspectorate America
reference the Web site listed below for Corporation is approved for the
a complete listing of CBP approved Inspectorate America Corporation has
been approved to gauge petroleum and following gauging procedures for
gaugers and accredited laboratories. petroleum and certain petroleum
http://www.cbp.gov/about/labs- certain petroleum products for customs
purposes for the next three years as of products from the American Petroleum
scientific/commercial-gaugers-and-
asabaliauskas on DSK3SPTVN1PROD with NOTICES
June 21, 2016. Institute (API):
laboratories.
DATES: The approval of Inspectorate
Dated: February 23, 2017. API chapters Title
America Corporation as commercial
Ira S. Reese, gauger became effective on June 21, 3 ..................... Tank Gauging.
Executive Director, Laboratories and 2016. The next triennial inspection date 5 ..................... Metering.
Scientific Services Directorate. will be scheduled for June 2019. 7 ..................... Temperature Determination.
[FR Doc. 2017–03992 Filed 2–28–17; 8:45 am] FOR FURTHER INFORMATION CONTACT: 8 ..................... Sampling.
BILLING CODE 9111–14–P Approved Gauger and Accredited 12 ................... Calculations.
VerDate Sep<11>2014 18:09 Feb 28, 2017 Jkt 241001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\01MRN1.SGM 01MRN1](https://thefederalregister.org/doc/82_FR_12269/page/3.svg)
Document Created: 2017-03-01 03:39:15
Document Modified: 2017-03-01 03:39:15
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). | |
| FR Citation | 82 FR 12230 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR